Disclosures for "Description of Gastrointestinal Symptoms in Patients with New-onset Refractory Status Epilepticus (NORSE)"
-
Miss Shrestha has nothing to disclose.
-
Prof. Silveira has nothing to disclose.
-
Ms. Thomas has nothing to disclose.
-
Dr. Leech has nothing to disclose.
-
The institution of Yi-Chen Lai has received research support from NIH.
-
Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biomarin. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for J. Kiffin Penry Foundation. An immediate family member of Dr. Riviello has received publishing royalties from a publication relating to health care. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Visiting Professor with University of Utah. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Visiting Professor with University of Calgary.
-
An immediate family member of Eyal Muscal has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. An immediate family member of Eyal Muscal has stock in Pfizer .
-
Dr. Soden has nothing to disclose.
-
The institution of Dr. Eschbach has received research support from Neurocrine Biosciences. The institution of Dr. Eschbach has received research support from UCB Biopharma. The institution of Dr. Eschbach has received research support from Pediatric Epilepsy Research Foundation. Dr. Eschbach has a non-compensated relationship as a Medical Science Advisory Board Member with NORSE Institute that is relevant to AAN interests or activities.